HCM
CLDI.WS
Highbridge Capital Management’s Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 CLDI.WS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Hold |
0
| – | -$20.7K | – | 375 |
|
|
2024
Q3 | – | Hold |
0
| – | -$68.1K | – | 284 |
|
|
2024
Q2 | – | Hold |
0
| – | -$84.7K | – | 208 |
|
|
2024
Q1 | – | Hold |
0
| – | -$81.4K | – | 190 |
|
|
2023
Q4 | – | Hold |
0
| – | -$342K | – | 167 |
|
|
2023
Q3 | – | Hold |
0
| – | -$85.7K | – | 140 |
|
|
2023
Q2 | – | Hold |
0
| – | -$19K | – | 210 |
|
|
2023
Q1 | – | Hold |
0
| – | -$22K | – | 388 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 427 |
|
|
2022
Q3 | – | Hold |
0
| – | -$33K | – | 738 |
|
|
2022
Q2 | – | Hold |
0
| – | -$196K | – | 681 |
|
|
2022
Q1 | – | Hold |
0
| – | -$254K | – | 502 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 445 |
|